Search results
Kronos Bio Starts Dosing In Early-Stage Leukemia Study With Next-Gen SYK Inhibitor
Benzinga via Yahoo Finance· 2 years agoThe first patient was dosed in Kronos Bio Inc's (NASDAQ: KRON) Phase 1b/2 trial of lanraplenib in...
UPS downgraded, Stryker upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 3 months agoUPS downgraded, Stryker upgraded: Wall Street's top analyst calls The most talked about and market...
Labcorp (LH) Presents New Research on Precision Diagnostics
Zacks via Yahoo Finance· 1 month agoLabcorp's (LH) new research shows how biomarker testing can help close testing gaps and guide...
3 Penny Stocks With Surprisingly Superior Fundamentals
InvestorPlace via Yahoo Finance· 2 years agoThe question of when to add risk to a portfolio is a difficult one to answer. A rush toward riskier...